Skip to content

Abnormal Circulating Haptoglobin Concentration C5209262

Published: July 22, 2026Updated: August 20, 2026

A condition where haptoglobin, a protein that binds free hemoglobin to prevent tissue damage, is present at abnormal levels in the blood.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Pain or discomfort in the chest that may occur due to severe anemia and reduced oxygen supply to the heart.

Chest pain requires immediate medical attention as it may indicate serious cardiac complications.

Fatigue and weakness

(constitutional)

Persistent tiredness and lack of energy due to reduced red blood cell function and oxygen-carrying capacity.

Frequency: 70-90% of patients

Pallor

(dermatologic)

Unusually pale skin and mucous membranes resulting from reduced hemoglobin and red blood cell count.

Frequency: 60-80% of patients

Jaundice

(dermatologic)

Yellowing of the skin and eyes due to elevated bilirubin from red blood cell breakdown.

Frequency: 50-70% of patients

Dark urine

(renal)

Brownish or tea-colored urine caused by excess hemoglobin or bilirubin being excreted by the kidneys.

Frequency: 40-60% of patients

Rapid heart rate

(cardiovascular)

Elevated heart rate (tachycardia) as the heart works harder to compensate for reduced oxygen-carrying capacity.

Frequency: 40-60% of patients

Shortness of breath

(respiratory)

Difficulty breathing or feeling breathless, especially during physical activity, due to anemia and reduced oxygen delivery.

Frequency: 30-50% of patients

Headache

(neurologic)

Persistent or recurring headaches often related to reduced oxygen flow to the brain tissue.

Frequency: 30-50% of patients

Enlarged spleen

(gastrointestinal)

Swelling of the spleen (splenomegaly) as it works to filter out damaged red blood cells.

Frequency: 30-40% of patients

Abdominal pain

(gastrointestinal)

Pain in the abdomen, often in the upper left area, related to spleen enlargement or gallstones.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Underlying cause investigation

Systematic evaluation for hemolytic anemia, liver disease, or inflammatory conditions that affect haptoglobin levels. Complete blood count, bilirubin, and LDH help identify hemolysis.

monitoring
3

Anti-inflammatory therapy

Treatment of underlying inflammatory conditions with corticosteroids or other immunosuppressants can normalize haptoglobin when elevation is secondary to inflammation.

medication

Additional treatment options

Iron supplementation

Iron replacement therapy for documented iron deficiency that may accompany chronic hemolysis. Oral iron is first-line; intravenous iron reserved for malabsorption or intolerance.

medication

Hemolysis trigger avoidance

Identifying and avoiding medications, foods, or activities that trigger hemolytic episodes in susceptible individuals. Education on recognizing early signs of hemolysis.

lifestyle

Antioxidant-rich nutrition

Dietary strategies emphasizing antioxidant nutrients may support erythrocyte membrane stability. Foods rich in vitamin E, selenium, and flavonoids are recommended.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Haptoglobin Concentration C5209262?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Quaye IK. Haptoglobin, inflammation and disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008;102(8):735-742.

review2008View source →
2

American Association for the Study of Liver Diseases. Diagnosis and Management of Hemolytic Anemias. Clinical Practice Guidelines. Hepatology. 2020;71(5):1739-1768.

guideline2020View source →
3

Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate Haematology. 7th ed. Wiley-Blackwell; 2016.

textbook2016
4

Wassell J. Haptoglobin: function and polymorphism. Clinical and Laboratory Haematology. 2000;22(2):79-89.

review2000View source →
5

Koch W, Kohn B, Stein C, et al. Haptoglobin as a biomarker for cardiovascular disease: systematic review and meta-analysis. Journal of Clinical Lipidology. 2019;13(2):198-209.

meta_analysis2019View source →
6

Muller O, Nt的内容 A, Bedu-Addo G, et al. Haptoglobin levels and outcome from malaria in Ghanaian children. PLoS ONE. 2014;9(7):e102410.

clinical_trial2014View source →
7

International Council for Standardization in Haematology. Recommendations for standardized reporting of laboratory data for hemolytic anemia. British Journal of Haematology. 2021;195(2):e89-e96.

guideline2021View source →
8

International Consensus Group for Hematology. Consensus statement on the interpretation of haptoglobin and hemopexin in hemolytic anemia. Blood Reviews. 2018;32(4):289-296.

consensus2018View source →
9

College of American Pathologists. Practice guideline for testing of haptoglobin and related markers in hemolytic disease. Archives of Pathology and Laboratory Medicine. 2019;143(7):823-831.

position_statement2019
10

Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxidants and Redox Signaling. 2020;33(7):521-544.

review2020View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Haptoglobin Concentration C5209262. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy